Write For Us

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

Sponsored Post Vitamin D2 Canada Persia
74 Views
Published
Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19, according to data from Phase III trials conducted on 25,800 participants across India. Sources said trial data and results were studied and recommended for approval by the DCGI's Subject Expert Committee on Tuesday. The data was submitted to the DCGI over the weekend.

About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe to our channels:
NDTV: https://www.youtube.com/user/ndtv?sub_confirmation=1
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindia?sub_confirmation=1

Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps:
http://www.ndtv.com/page/apps

Watch More Videos:
http://www.ndtv.com/video?yt

#BreakingNews #LatestNews #TodayNews #PoliticalNews #News
Category
Asia
Tags
NDTV 24x7, Coronavirus, Covid vaccine
Sign in or sign up to post comments.
Be the first to comment